Home > Psychiatry > ECNP 2021 > COVID-19 > ECNP 2021 Highlights Podcast

ECNP 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ECNP 2021
Trial
WATERFALL, RECONNECT
In this episode (20:56 min), Medicom’s correspondent covers 6 presentations from the European College of Neuropsychopharmacology (ECNP 2021), held virtually 2–5 October 2021. The topics discussed are:   1. Zuranolone reduces symptoms of major depression Results from the pivotal WATERFALL study of zuranolone in patients with major depressive disorder (MDD) showed a statistically significant and clinically meaningful reduction in depressive symptoms after 15 days. Zuranolone is a novel, oral, neuroactive steroid and GABAA-receptor positive allosteric modulator. 2.


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on